Minor Use Minor Species Development of Drugs: Research Project Grant

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, more commonly referred to as NIH, is an agency operating under the United States Department of Health and Human Services that is primarily accountable for funding and supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all designed to contribute to the agency's general mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

The grant project seeks to solicit applications and proposals from eligible institutions and organizations who are willing to design and develop brand new animal drugs that are solely exclusive for minor use in major species or minor species.

In the year 2004, the The Minor Use and Minor Species Animal Health Act was constituted and this law enabled veterinarians to have legal access to more medications that are effective in the management and treatment of disease conditions that are common in minor animal species and minor uses in major animal species.

  (continued...)

Minor Use Minor Species Development of Drugs: Research Project Grant
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on philanthropy giving and community grants.

Additional Resources

category - Health Grants

Human Health and Heredity in Africa: Research Grants Program
The Human Health and Heredity in Africa: Research Grants Program wherein they intend to invite applications from foreign institutions that are based in African countries who have the desire to conduct scientific studies regarding the genomic/genetic/environmental contributors of human health and diseases which are common in Africa.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Targeting Persistent HIV Reservoirs Grant Program
In keeping with this mission, the National Institutes of Health has recently formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH) in order to establish the Targeting Persistent HIV Reservoirs Grant Program.

---